Christine Diamond

Christine Diamond has worked in various roles in the research field since 2009. Christine began their career as a Research Scientist at Acucela Inc. in 2009, where they studied Diabetic Retinopathy in multiple rodent models and developed a rodent model of angiogenesis. In 2010, they moved to SNBL USA as a Research Associate and then to SightLife in 2014 as a Tissue Processing. In 2015, they returned to Acucela Inc. as a Senior Research Scientist and in 2019 they joined NodThera Limited as an Associate Research Scientist and later as a Research Scientist. During their time at Acucela Inc., Christine developed a novel murine model of AMD, participated in weekly group meetings and presented data at joint cross functional research team meetings.

Christine Diamond obtained a Bachelor of Arts in Behavioral Neuroscience from Western Washington University in 2008. In 2011, they obtained a LAT certification.